Malignant Osteogenic Sarcomas

Pediatric Oncology Use of Cabozantinib in addition to chemotherapy as a viable second line treatment option in Relapsed Refractory Malignant Osteogenic Sarcomas
Dale Jude Montes • Maharshi Trivedi • Helie Raval • Himangi Tak • Chinmay Doctor • Harsha Panchal
doi.org/10.69690/ODMJ-018-0425-2488